Physician profile

Payam Shadi

Sleep Medicine (Internal Medicine) · Los Angeles, CA

NPI 1780615724

$9,723.08

in general payments reported to CMS, 2019-2025

46 companies · $1,407 in 2025

The $1,407 reported for 2025 was more than what 79% of Sleep Medicine (Internal Medicine) providers received nationally (typical 2025 total: $447).

See the full distribution for Sleep Medicine (Internal Medicine)

Payments by year

General payments by program year, as reported to CMS.

What the payments were for

Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.

View as a table
Payment typeAmount (2023-2025)
Food and Beverage$3,540.48
Travel and Lodging$99.33
Education$18.72

Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.

Who reported paying

General payments only, as reported to CMS. Product names cover 2023-2025.

CompanyGeneral paymentsYearsTop products
Janssen Pharmaceuticals, INC $1,700.79 2019-2024 Spravato, Xarelto
Bayer Healthcare Pharmaceuticals INC. $1,051.97 2021-2025
Astrazeneca Pharmaceuticals LP $794.88 2019-2025 Breztri, Farxiga, Airsupra
Pfizer INC. $584.97 2019-2024
Nobel Biocare USA $529.97 2019-2022
Novartis Pharmaceuticals Corporation $480.13 2019-2025
Lilly USA, LLC $399.07 2019-2025 Mounjaro, Baqsimi, Lyumjev
Salix Pharmaceuticals, A Division of Bausch Health US, LLC $366.01 2019-2024 Xifaxan
Jazz Pharmaceuticals INC. $358.10 2023-2025 Xywav
Amgen INC. $347.49 2020-2025 Repatha, Repatha, Otezla
Boehringer Ingelheim Pharmaceuticals, INC. $328.21 2020-2024 Jardiance, Synjardy
Harmony Biosciences LLC $289.10 2022-2024 Wakix
Abbvie INC. $285.70 2019-2025
Boston Scientific Corporation $270.70 2025 Icefx Cryoablation System
Nestle Healthcare Nutrition INC. $220.75 2020-2023
Show all 46 companies
CompanyGeneral paymentsYearsTop products
E.R. Squibb & Sons, L.L.C. $206.13 2019-2024 Camzyos
Novo Nordisk INC $189.47 2021-2025 Ozempic, Tresiba, Rybelsus
Glaxosmithkline, LLC. $163.47 2020-2024 Trelegy Ellipta
Zoll Services LLC (A/K/A Zoll Lifecor Corp) $127.43 2023-2024 Lifevest
Eisai INC. $94.05 2020-2021
Corcept Therapeutics $84.65 2023 Korlym
Astellas Pharma US INC $67.14 2019
Philips North America LLC $60.01 2024 (Ak6) Vest Therapy
Evoke Pharma, INC. $59.81 2022
Allergan, INC. $55.39 2019-2020
Melinta Therapeutics, LLC $51.43 2020-2021
Cardiovascular Systems INC. $50.00 2019
Mannkind Corporation $44.23 2020
Ironwood Pharmaceuticals, INC $42.44 2020-2021
Sanofi-Aventis U.S. LLC $39.81 2021-2022
Idorsia Pharmaceuticals US INC $34.82 2023 Quviviq
Shield Therapeutics INC $33.55 2025
Itamar Medical INC $30.82 2022-2024 Watchpatone
Sumitomo Pharma America, INC. $27.15 2025 Gemtesa
Radius Health, INC. $26.03 2019
Aytu Biopharma, INC. $24.92 2019
Xeris Pharmaceuticals, INC. $24.61 2022
Heartflow, INC. $24.11 2023 Ffrct
Abbott Laboratories $23.37 2023 Freestyle Libre 3
Amarin Pharma, INC. $21.80 2021
Sun Pharmaceutical Industries INC. $21.67 2021
Dexcom, INC. $20.36 2021
Nabriva Therapeutics, Plc $18.71 2021
Exact Sciences Corporation $17.18 2025 The Cologuard Plus Collection Kit
Medtronic, INC. $16.79 2022
Esperion Therapeutics, INC. $13.89 2024 Nexletol

Drugs and devices associated with these payments

CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.

If you want to bring it up

Most clinicians are glad to talk about this. A respectful way in:

These are normal questions. A good clinician will welcome them.

Share this page

Payment summary

Payam Shadi

$9,723.08

in general payments reported 2019-2025

Years
2019-2025
Top company
Janssen Pharmaceuticals, INC
Context
The $1,407 reported for 2025 was more than what 79% of Sleep Medicine (Internal Medicine) providers received nationally (typical 2025 total: $447).

https://glasscript.com/doctor/35847/payam-shadi

Source: CMS Open Payments, program years 2019-2025. Payments are legal and often routine.

Keep an eye on this page

Get an email when the next June refresh changes this page. No account needed.

Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.